<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02170883</url>
  </required_header>
  <id_info>
    <org_study_id>H14-01451</org_study_id>
    <nct_id>NCT02170883</nct_id>
  </id_info>
  <brief_title>EmPhAsIS: Empowering Pharmacists in Asthma Management Through Interactive SMS</brief_title>
  <official_title>EmPhAsIS: Empowering Pharmacists in Asthma Management Through Interactive SMS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>WelTel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>College of Pharmacists of British Columbia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Between 8% and 12% of Canadians suffer from asthma. Although there are effective and
      inexpensive treatments, adherence to asthma treatment is amongst the lowest for all chronic
      diseases.The purpose of this study is to determine whether enhancing the role of community
      pharmacists in asthma management using interactive short messaging service (SMS) with asthma
      patients is a cost-effective model that will improve adherence to inhaled corticosteroid
      medications compared to usual care.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence to inhaled corticosteroid medication</measure>
    <time_frame>12 months</time_frame>
    <description>Adherence assessed by medication possession ratio</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Asthma control</measure>
    <time_frame>Baseline</time_frame>
    <description>Asthma control assessed by the Asthma Control Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma control</measure>
    <time_frame>6 months</time_frame>
    <description>Asthma control assessed by the Asthma Control Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma control</measure>
    <time_frame>12 months</time_frame>
    <description>Asthma control assessed by the Asthma Control Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Baseline</time_frame>
    <description>Quality of life measured by the Asthma Quality of Life Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>3 months</time_frame>
    <description>Quality of life measured by the Asthma Quality of Life Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>12 months</time_frame>
    <description>Quality of life measured by the Asthma Quality of Life Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health care resource utilization</measure>
    <time_frame>12 months</time_frame>
    <description>Asthma-related hospital admissions and emergency department visits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of reliever medication for acute asthma attacks</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">370</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Interactive SMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention with interactive SMS (text messaging) by which patients are asked to disclose their level of agreement with the following statement &quot;I follow my asthma medication plan&quot; and pharmacist follow-up</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pharmacist conducted patient education, counseling and action-plan</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Interactive SMS</intervention_name>
    <arm_group_label>Interactive SMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <arm_group_label>Usual care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  individuals who fill a (incident or prevalent) prescription for inhaled
             corticosteroids (either monotherapy or in combination inhaler with long-acting
             beta-agonists) who have been diagnosed by a doctor as having asthma

          -  possessing a cell-phone with ability to send/receive text messages

          -  residing in British Columbia (BC), Canada and planning to reside in BC for the next 12
             months

          -  registered with the medical services plan (MSP, the provincial insure of
             medically-required services) in the past 12 months, and planning to remain registered
             for the next 12 months

          -  designated pharmacy being the main drugstore for patient

          -  not participating in another interventional study

          -  consent to participate in the study.

        Exclusion Criteria:

          -  Unable to communicate in English

          -  Under 14 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mary De Vera, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Natasha Campbell, MSc</last_name>
    <phone>604-827-1567</phone>
    <email>natasha.campbell@ubc.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>UBC</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6T 1Z3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natasha Campbell, MSc</last_name>
      <phone>604-827-1567</phone>
      <email>natasha.campbell@ubc.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 19, 2014</study_first_submitted>
  <study_first_submitted_qc>June 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2014</study_first_posted>
  <last_update_submitted>March 6, 2018</last_update_submitted>
  <last_update_submitted_qc>March 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Mary De Vera</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>asthma</keyword>
  <keyword>mHealth</keyword>
  <keyword>cluster randomized controlled trial</keyword>
  <keyword>pharmacy practice</keyword>
  <keyword>pharmacist</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

